trending Market Intelligence /marketintelligence/en/news-insights/trending/qtey5spchulny32iok8mag2 content esgSubNav
In This List

Mersana Therapeutics appoints CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Mersana Therapeutics appoints CFO

Mersana Therapeutics Inc. appointed David Spellman to the position of CFO.

Most recently, Spellman served as vice president of corporate, commercial and international finance at Vertex Pharmaceuticals Inc.